What is the price-to-earnings ratio of MEI Pharma?
The price-earnings ratio of MEI Pharma is currently 0.79.
MEI Pharma P/E 2024
MEI Pharma P/E
0.79
Ticker
MEIP
ISIN
US55279B2025
WKN
A1KATX
As of Jun 27, 2024, MEI Pharma's P/E ratio was 0.79, a -150% change from the -1.58 P/E ratio recorded in the previous year.
The MEI Pharma P/E history
MEI Pharma Aktienanalyse
What does MEI Pharma do?
MEI Pharma Inc. is a pharmaceutical company focused on the development and commercialization of cancer-related therapeutics. It was founded in 2000 and is headquartered in San Diego, California. MEI Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/E Details
Deciphering MEI Pharma's P/E Ratio
The Price to Earnings (P/E) Ratio of MEI Pharma is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.
Year-to-Year Comparison
Assessing MEI Pharma's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.
Impact on Investments
The P/E ratio of MEI Pharma is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.
Interpreting P/E Ratio Fluctuations
Fluctuations in MEI Pharma’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.
Frequently Asked Questions about MEI Pharma Stock
How has the price-earnings ratio of MEI Pharma changed compared to last year?
The price-to-earnings ratio of MEI Pharma has increased by -150% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of MEI Pharma high compared to other companies?
Yes, the price-to-earnings ratio of MEI Pharma is high compared to other companies.
How does an increase in the price-earnings ratio of MEI Pharma affect the company?
An increase in the price-earnings ratio of MEI Pharma would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of MEI Pharma affect the company?
A decrease in the price-earnings ratio of MEI Pharma would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of MEI Pharma?
Some factors that influence the price-earnings ratio of MEI Pharma are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does MEI Pharma pay?
Over the past 12 months, MEI Pharma paid a dividend of 1.75 USD . This corresponds to a dividend yield of about 61.19 %. For the coming 12 months, MEI Pharma is expected to pay a dividend of 1.75 USD.
What is the dividend yield of MEI Pharma?
The current dividend yield of MEI Pharma is 61.19 %.
When does MEI Pharma pay dividends?
MEI Pharma pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MEI Pharma?
MEI Pharma paid dividends every year for the past 0 years.
What is the dividend of MEI Pharma?
For the upcoming 12 months, dividends amounting to 1.75 USD are expected. This corresponds to a dividend yield of 61.19 %.
In which sector is MEI Pharma located?
MEI Pharma is assigned to the 'Health' sector.
Wann musste ich die Aktien von MEI Pharma kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MEI Pharma from 12/6/2023 amounting to 1.75 USD, you needed to have the stock in your portfolio before the ex-date on 11/16/2023.
When did MEI Pharma pay the last dividend?
The last dividend was paid out on 12/6/2023.
What was the dividend of MEI Pharma in the year 2023?
In the year 2023, MEI Pharma distributed 0 USD as dividends.
In which currency does MEI Pharma pay out the dividend?
The dividends of MEI Pharma are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The MEI Pharma stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von MEI Pharma
Our stock analysis for MEI Pharma Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MEI Pharma Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
